✦ LIBER ✦

Chemotherapy for hormone-refractory prostate cancer: Beauty is in the eye of the beholder

✍ Scribed by Tomasz Beer; Derek Raghavan

Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 143 KB
Volume: 45
Category: Article
ISSN: 0270-4137
DOI: 10.1002/1097-0045(20001001)45:2<184::aid-pros13>3.0.co;2-k

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Oral etoposide in the treatment of hormo

Oral etoposide in the treatment of hormone-refractory prostate cancer

✍ Maha H. Hussain; Kenneth J. Pienta; Bruce G. Redman; Glenn D. Cummings; Lawrence 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 340 KB 👁 2 views

The use of flutamide in hormone-refracto

The use of flutamide in hormone-refractory metastatic prostate cancer

✍ D. G. McLeod; R. C. Benson Jr; M. A. Eisenberger; E. D. Crawford; B. A. Blumenst 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 444 KB 👁 2 views

Amplification of the androgen receptor g

Amplification of the androgen receptor gene is associated with P53 mutation in hormone-refractory recurrent prostate cancer

✍ Koivisto, Pasi A.; Rantala, Immo 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 257 KB 👁 2 views

p53 protein expression of 30 hormone-refractory locally recurrent prostate cancers was compared with their matched untreated primary tumour specimens. In addition, androgen receptor (AR) gene amplification and p53 protein immunostaining were compared. p53 positivity increased during hormonal therapy

Is there a role for short-term hormone u

Is there a role for short-term hormone use in the treatment of nonmetastatic prostate cancer?

✍ Eric M. Horwitz; Alexandra L. Hanlon; Wayne H. Pinover; Gerald E. Hanks 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB 👁 1 views

Considerations for the use of testostero

Considerations for the use of testosterone with systemic chemotherapy in prostatic cancer

✍ Jackson E. Fowler Jr.; Willet F. Whitmore Jr. 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 445 KB 👁 1 views

The dynamics of prostate specific antige

The dynamics of prostate specific antigen in hormone refractory prostate carcinoma : An analysis of Cancer and Leukemia Group B Study 9181 of megestrol acetate

✍ Robin T. Vollmer; Nancy A. Dawson; Nicholas J. Vogelzang 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB 👁 2 views

## BACKGROUND. Although many physicians measure serum prostate specific antigen (PSA) during the follow-up of patients with hormone refractory prostate carcinoma (HRPC), little has been done to formalize the determination of how these serial values of PSA impact on prognosis. To understand HRPC fu